Andy Wright has 20 years experience leading global health programmes improving the lives of people in the developing world. Andy’s early career includes project management of capital projects within the petrochemical construction industry, roles in marketing and business development, and project management consultancy.
Andy worked for the pharmaceutical company GSK from 1994 to 2019 in various roles, however from 2000 joined the global programme to eliminate the disease Lymphatic Filariasis (LF). Andy managed the donation of the medicine albendazole, which has now exceeded 8 billion doses to more than 80 countries, to combat LF and treat school-age children for intestinal worms.
As Vice President of Global Health Programmes at GSK, Andy was responsible for leading the team implementing GSK’s portfolio of donation and grant making programmes aimed at improving the health of underserved people in the developing world. These included the donation of albendazole for neglected tropical diseases, a partnership with Comic Relief to combat Malaria, a partnership with Save the Children improving the lives of children in Africa and Asia, training of health workers in 40 Least Developed Countries, partnerships to strengthen academic institutions, humanitarian response and programmes to improve access to medicines.
Andy has travelled extensively to over 60 countries, including more than 30 in South America, Africa, Asia and the Pacific, to visit programmes supported by GSK.
Andy retired from GSK in 2019 and is now Director of Wright Global Health Consulting, focusing on tropical diseases affecting people in the developing world.
Andy has a Bachelors Degree in Civil Engineering and a Masters Degree in Project Management.